Committee MeetingSenateMeeting
Hearings to examine Novo Nordisk's high prices for Ozempic and Wegovy for patients with diabetes and obesity.
Held
Tuesday, September 24, 2024
Dirksen Senate Office Building 562
Held by
Senate Health, Education, Labor, and Pensions